Moderna, Inc. (NASDAQ:MRNA) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET
Company Participants
Lavina Talukdar – Senior Vice President, Investor Relations
Stephane Bancel – Chief Executive Officer
Jamey Mock – Chief Financial Officer
Stephen Hoge – President
Conference Call Participants
Salveen Richter – Goldman Sachs
Tyler Van Buren – TD Cowen
Cory Kasimov – Evercore ISI
Courtney Breen – Bernstein
Dick Gottfred – William Blair
Gena Wang – Barclays
Operator
Good day, and thank you for standing by. Welcome to the Moderna First Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Instructions] Please be advised, today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, Lavina Talukdar,
Head of Investor Relations at Moderna. Please go ahead.
Lavina Talukdar
Thank you, Kevin. Good morning, everyone, and thank you for joining us on today’s call to discuss Moderna’s first quarter 2025 financial results and business updates. You can access the press release issued this morning as well as the slides that we will be reviewing by going to the Investors section of our website.
On today’s call are Stephane Bancel, our Chief Executive Officer; Stephen Hoge, our President and Jamey Mock, our Chief Financial Officer. Before we begin, please note that this conference call will include forward-looking statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide 2 of the accompanying presentation and our SEC filings for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in these forward-looking statements.
With that, I will now turn the call over to Stephane.
Stephane Bancel
Thank you, Lavina. Good
#Moderna #MRNA #Earnings #Call #Transcript